Chief Research & Development Officer (CRDO)

Role Purpose & Context

Role Summary

The Chief Research & Development Officer (CRDO) is here to define and drive our global R&D strategy, from early discovery right through to regulatory approval. You'll be the one setting the overarching scientific vision, deciding which therapeutic areas we chase, and making sure our labs worldwide are working together like a well-oiled machine. This role directly impacts our ability to discover, develop, and deliver life-changing medicines, so no pressure, eh? Day-to-day, you'll be balancing long-term, ambitious scientific goals with the harsh realities of commercial viability and investor expectations. You're the bridge between pure science and market success. When this role is done well, we're launching innovative products that genuinely help people, our pipeline is robust, and our investors are happy. When it's not, we're burning through cash on dead-end projects and missing crucial market opportunities. The challenge? It's about making multi-million-pound bets with incomplete data, navigating complex global regulations, and keeping a diverse, brilliant scientific team focused and motivated. The reward, though? Seeing years of scientific effort culminate in a product that saves lives. That's pretty special, honestly.

Reporting Structure

• Reports to: Chief Executive Officer (CEO) and Board of Directors
• Direct reports: VP, R&D; Director, Therapeutic Area R&D; Head of Global Regulatory Affairs
• Matrix relationships: Chief Scientific Officer (CSO), Global Head of Research & Development, Executive Vice President, R&D,

Key Stakeholders

Internal:

• Chief Executive Officer (CEO)
• Board of Directors
• Chief Financial Officer (CFO)
• Chief Commercial Officer (CCO)
• Chief Operating Officer (COO)
• Head of Legal & Compliance

External:

• Investors and Analysts
• Regulatory Bodies (e.g., MHRA, EMA, FDA)
• Key Opinion Leaders (KOLs)
• Strategic Research Partners & CROs
• Industry Associations

Organisational Impact

Scope: This role directly shapes the company's long-term viability and market position. You're accountable for the entire R&D portfolio, its success rates, and the strategic allocation of hundreds of millions of pounds. Your decisions dictate our scientific reputation, our intellectual property estate, and ultimately, our ability to deliver on our mission to patients and shareholders.

Performance Metrics

Quantitative Metrics

1. Metric: R&D Pipeline Progression Rate
2. Desc: The percentage of projects successfully advancing through key development gates (e.g., from pre-clinical to Phase 1, Phase 2 to Phase 3).
3. Target: Improve progression rates by 10% year-on-year across the portfolio.
4. Freq: Quarterly and Annually
5. Example: If we had 10 projects in pre-clinical last year and 7 made it to Phase 1, we'd want 7.7 or more this year, assuming a similar starting point. It's about getting more shots on target.
6. Metric: Successful Regulatory Submissions
7. Desc: The number of successful Investigational New Drug (IND) or Biologics License Application (BLA)/New Drug Application (NDA) submissions and approvals.
8. Target: Achieve 1-2 successful IND submissions and 1 BLA/NDA approval every two years.
9. Freq: Annually
10. Example: Securing EMA approval for our lead oncology candidate in Q4 2026, opening up the European market. That's a huge win, obviously.
11. Metric: R&D Budget Adherence
12. Desc: Managing the multi-million-pound global R&D budget within approved variances.
13. Target: Maintain R&D spend within +/- 5% of the approved annual budget.
14. Freq: Monthly and Quarterly
15. Example: If the annual budget is £100M, you're expected to stay between £95M and £105M. Overspending without a very, very good reason isn't an option.
16. Metric: Intellectual Property (IP) Portfolio Growth
17. Desc: The number of new patent applications filed and granted, and the strategic value of the IP estate.
18. Target: Increase patent filings by 15% annually, focusing on high-value, defensible IP.
19. Freq: Annually
20. Example: Filing 20 new patent applications in 2027, up from 17 in 2026, covering novel drug delivery systems and biomarker assays. We're building that IP moat, you see.

Qualitative Metrics

1. Metric: Investor & Board Confidence
2. Desc: The level of trust and confidence from investors and the Board in the R&D strategy and execution.
3. Evidence: Positive feedback during quarterly earnings calls; Board readily approves strategic R&D investments; Investor presentations are well-received and don't raise red flags. Frankly, they trust your judgment.
4. Metric: Scientific & Industry Reputation
5. Desc: The company's standing within the scientific community and the broader pharmaceutical/biotech industry.
6. Evidence: Key Opinion Leaders (KOLs) actively seek collaboration; Your team's research is published in top-tier journals; We're seen as an employer of choice for top scientific talent. People want to work with us, and for us.
7. Metric: Strategic Partnership Success
8. Desc: The effectiveness and value generated from external research collaborations and partnerships.
9. Evidence: Successful joint ventures leading to new pipeline candidates; Partners actively seeking to renew or expand agreements; Positive feedback from partner organisations on joint project outcomes. It's about making those relationships truly work.
10. Metric: Organisational Health & Talent Retention
11. Desc: The ability to attract, develop, and retain top scientific and R&D leadership talent.
12. Evidence: Low attrition rates for critical R&D roles (<10% annually); High engagement scores in R&D departments; A clear internal succession plan for key leadership positions. We want our best people to stay and grow.

Primary Traits

• Trait: Decisive (with incomplete data)
• Manifestation: You're the person who can make the final 'go/no-go' call on a multi-year, multi-million-pound project after a Phase 1 data readout shows ambiguous results. This means shutting down a pet project of a senior scientist because it's simply not hitting predefined milestones. You'll reallocate significant resources from a 'safe' project to a high-risk, high-reward one, knowing the stakes are incredibly high. It's about making the tough call when the data isn't 100% clear, which, let's be honest, it rarely is in R&D.
• Benefit: Research and Development is a funnel of attrition, and every day of hesitation or 'analysis paralysis' wastes millions in budget and months of precious time. This role absolutely requires making the tough call to kill projects to free up resources for potential winners, even when it's unpopular. Your ability to make these calls quickly and confidently directly impacts our speed to market and financial health.
• Trait: Influential (beyond authority)
• Manifestation: You'll be convincing the CFO to fund a new £5M mass spectrometry platform by building a rock-solid business case based on future efficiency gains and scientific breakthroughs. This also means persuading the commercial team to accept a more realistic, often longer, product launch timeline based on genuine technical hurdles, rather than their ambitious sales targets. You'll need to align lab heads in the US, Germany, and Japan on a single, harmonised analytical platform, even when they've all got their own preferences. It's about getting people on board, not just telling them what to do.
• Benefit: While this role has formal authority over our global labs, true success depends on influencing peers, the CEO, and the Board without direct hierarchical control over their domains. You need to build coalitions, articulate a compelling scientific and commercial vision, and secure the resources and strategic direction needed to deliver. Your ability to influence is, frankly, more important than your title.
• Trait: Accountable (for team failures)
• Manifestation: You'll stand before the executive committee and take full ownership for a missed primary endpoint in a clinical trial, clearly explaining the scientific rationale, what was learned, and the revised plan forward. This isn't about blaming others. You'll shield a junior scientist (or even a Director) from public blame for a costly experimental error, instead focusing the entire R&D organisation on improving the process that allowed the error to happen. It's about owning the outcome, good or bad.
• Benefit: In a culture of innovation, failure is not just inevitable; it's a learning opportunity. If the leader punishes failure, the team will stop taking risks, hide problems, and ultimately stifle innovation. Public accountability from the top builds psychological safety across the entire R&D organisation, encouraging teams to push boundaries, report problems early, and learn from mistakes without fear of reprisal. This is crucial for long-term scientific success.

Supporting Traits

• Trait: Scientific Rigor
• Desc: An innate skepticism and a relentless demand for robust, reproducible data that forms the absolute foundation of your credibility with both scientists and regulators. You won't accept 'good enough' when it comes to the science.
• Trait: Pragmatic Visionary
• Desc: You balance the pursuit of groundbreaking science and long-term vision with the commercial realities of timelines, budgets, and market needs. It's about dreaming big, but with both feet on the ground.
• Trait: Resilience
• Desc: The ability to absorb significant setbacks, major project cancellations, and complex regulatory hurdles without losing momentum or demoralising a global team. You'll need a thick skin, honestly.
• Trait: Global Dexterity
• Desc: You understand and adapt to different cultural norms around communication, hierarchy, and work-life balance across our international lab sites. What works in London might not fly in Tokyo or Boston.

Primary Motivators

1. Motivator: Shaping the Future of Medicine
2. Daily: You'll spend your days making strategic decisions that directly impact which diseases we target and how we develop new treatments. You're constantly thinking about the next big scientific breakthrough and how to get it to patients.
3. Motivator: Building a World-Class Scientific Organisation
4. Daily: You're driven by the challenge of attracting, developing, and retaining the brightest scientific minds globally. You'll be designing the organisational structure, fostering a culture of innovation, and ensuring our labs have the best technology.
5. Motivator: Driving Commercial Success Through Innovation
6. Daily: You thrive on the intersection of science and business, seeing your scientific vision translate into market-leading products and significant returns for shareholders. You understand that great science needs to be commercially viable.

Potential Demotivators

Honestly, this role isn't for everyone. If you crave absolute scientific purity without commercial constraints, or if you struggle with constant political navigation and making tough, unpopular decisions, you'll find it incredibly frustrating. The reality is messier than the job posting suggests.

Common Frustrations

1. The 'Budget Death Spiral': Fighting for an innovative, high-risk project for two quarters, only to have its multi-million-pound budget cut in Q3 to fund a 'safer' incremental improvement requested by the commercial team. It's soul-destroying sometimes.
2. The 'Talent War' at the top: Spending six months recruiting a specialised immunologist to lead a new division, only to have them poached by a startup with pre-IPO stock options you simply can't compete with. It's a constant battle.
3. Regulatory Whack-a-Mole on a global scale: Receiving feedback from the FDA that requires a major change to an analytical method, which then puts you in direct conflict with previously agreed-upon specifications with the EMA. Harmonisation is a nightmare.
4. The 'Science Project' Problem writ large: The constant battle to keep brilliant scientists across the globe focused on commercially viable goals, rather than pursuing intellectually fascinating but strategically irrelevant research. It's a delicate balance.
5. Inherited Tech Debt that impacts the entire organisation: Being hamstrung by a 15-year-old, poorly documented LIMS system that the entire global QC network relies on, making any innovation or integration a multi-year, multi-million-pound nightmare. You get to fix someone else's mess.
6. The Translation Gap with the Board: Spending an hour explaining the statistical significance of a complex biomarker study to the Board, only to have them ask, 'So... is it good news or bad news for the share price?' It's a different language sometimes.

What Role Doesn't Offer

1. A quiet life focused solely on scientific discovery without commercial pressures.
2. Complete autonomy over R&D budget without significant Board and CEO oversight.
3. A predictable, stable environment where strategic directions rarely shift.
4. The opportunity to avoid difficult conversations about project termination or resource reallocation.

ADHD Positives

1. The need for rapid, decisive action in a high-stakes environment can be a huge strength, especially when traditional 'analysis paralysis' would be detrimental.
2. Exceptional ability to hyperfocus on critical, complex problems, often seeing patterns and connections others miss, which is vital for strategic R&D.
3. High energy levels and a drive for novelty can fuel the constant innovation required to lead a global R&D organisation.

ADHD Challenges and Accommodations

1. Managing a vast array of strategic initiatives and details can be overwhelming; strong executive assistants and robust project management frameworks are essential.
2. The need for consistent, clear communication from direct reports is crucial to avoid misinterpretations; structured reporting templates can help.
3. Long, complex board meetings might require strategies for maintaining focus; access to pre-reads and concise summaries can be helpful.

Dyslexia Positives

1. Often possess strong 'big picture' strategic thinking, seeing overarching patterns and connections that are critical for setting global R&D direction.
2. Excellent problem-solving skills, especially for complex, multi-faceted challenges that require non-linear thinking.
3. Strong verbal communication and storytelling abilities, which are invaluable for influencing investors, the Board, and scientific teams.

Dyslexia Challenges and Accommodations

1. Extensive reading and writing of detailed regulatory documents, board papers, and scientific publications can be demanding; access to proofreading support and text-to-speech software is available.
2. Ensuring clarity in written communications to global teams is paramount; using visual aids, concise bullet points, and having a trusted reviewer can help.
3. Complex data interpretation in written reports might benefit from graphical summaries and verbal debriefs to ensure full comprehension.

Autism Positives

1. Exceptional ability for deep, logical analysis and pattern recognition, which is critical for identifying scientific opportunities and risks.
2. A strong commitment to accuracy and scientific rigour, ensuring that all R&D processes and data meet the highest standards.
3. Direct and honest communication style, which can foster clarity and trust in high-stakes executive discussions.

Autism Challenges and Accommodations

1. Navigating complex organisational politics and unspoken social cues can be challenging; clear, direct communication from peers and the CEO is appreciated.
2. Frequent, unstructured social interactions and networking events might be draining; opportunities for focused, purposeful engagement are preferred.
3. Changes in strategic direction or unexpected shifts in priorities can be difficult; clear rationale and advanced notice help manage transitions.

Key Responsibilities

Experience Levels Responsibilities

1. Level: C-Suite (20+ years)
2. Responsibilities: Define the enterprise-wide R&D strategy and long-term scientific vision, ensuring it aligns with our overall business goals and market opportunities. This means looking 3-5 years out, minimum.
3. Govern the entire global R&D portfolio, making the ultimate go/no-go decisions on multi-million-pound projects based on scientific merit, commercial potential, and risk assessment. It's a heavy responsibility.
4. Lead and mentor a global team of VPs and Directors, fostering a culture of scientific excellence, innovation, and rigorous quality across all international lab sites. You're building the next generation of leaders.
5. Represent the company to the Board of Directors, investors, key regulatory bodies (e.g., MHRA, EMA, FDA), and major scientific conferences. You're the face of our science.
6. Oversee the development and management of the multi-£10M annual R&D budget, ensuring optimal allocation of resources to maximise pipeline value and achieve strategic objectives. Every pound counts.
7. Drive the identification, evaluation, and integration of new platform technologies and strategic partnerships that will enhance our R&D capabilities and competitive advantage. Always looking for the next big thing.
8. Ensure robust quality management systems (QMS) and regulatory compliance (GLP, GCP, GMP) across all R&D operations globally, safeguarding our data integrity and reputation. No shortcuts here.
9. Supervision: Fully autonomous on strategic execution, with regular alignment and reporting to the CEO and Board of Directors on enterprise-level strategy, performance, and major risks. You're accountable, but you're also trusted to lead.
10. Decision: Full authority over the global R&D budget (typically £10M+), enterprise-wide R&D strategy, major project go/no-go decisions, organisational design within R&D, and significant external commitments (e.g., multi-£M research partnerships). Board approval is required for M&A activity or changes to the overall company strategy.
11. Success: A robust, innovative R&D pipeline that consistently delivers successful regulatory submissions; strong investor confidence in our scientific direction; a high-performing, engaged global R&D team; and a reputation as a leader in scientific discovery and development.

Decision-Making Authority

• Type: Enterprise R&D Strategy & Vision
• Entry: N/A
• Mid: N/A
• Senior: Defines and champions the 3-5 year global R&D strategy. Presents to and aligns with the CEO and Board of Directors.
• Type: Global R&D Budget Allocation (£10M+)
• Entry: N/A
• Mid: N/A
• Senior: Owns the entire global R&D budget. Final approval for all major capital expenditures and resource allocation within R&D. Reports adherence to the CFO and Board.
• Type: Major Project Go/No-Go Decisions
• Entry: N/A
• Mid: N/A
• Senior: Makes the ultimate decision on whether to advance, pause, or terminate multi-million-pound R&D projects at key development gates. Informs the CEO and Board.
• Type: Organisational Design & Leadership Hires (R&D)
• Entry: N/A
• Mid: N/A
• Senior: Defines the organisational structure for the entire global R&D department. Final approval for all VP and Director-level hires within R&D. Consults with CEO on C-suite direct reports.
• Type: External Strategic Partnerships & M&A (R&D aspects)
• Entry: N/A
• Mid: N/A
• Senior: Identifies, evaluates, and leads negotiations for significant R&D-focused strategic partnerships. Provides critical scientific and integration input for M&A targets. Requires Board approval for M&A.

Competency Requirements

Foundation Skills (Transferable)

At this level, your foundation skills aren't just about doing; they're about leading, influencing, and setting the tone for an entire global organisation. Think less about executing a task and more about shaping the environment where those tasks happen.

• Category: Strategic Leadership & Vision
• Skills: Ability to define and articulate a compelling 3-5 year scientific vision that aligns with business objectives and inspires a global team.
• Expertise in translating complex scientific breakthroughs into clear, actionable strategic priorities for the organisation.
• Proven track record of making high-stakes, data-informed decisions in ambiguous environments, often with incomplete information.
• Category: Executive Communication & Influence
• Skills: Exceptional ability to communicate complex scientific and strategic information clearly and concisely to diverse audiences, including the Board, investors, regulators, and the scientific community.
• Mastery of negotiation and persuasion, capable of building consensus and driving alignment across C-suite peers and external partners.
• Strong public speaking and presentation skills, able to represent the company with authority and credibility at global forums.
• Category: Organisational Development & Talent Management
• Skills: Experience in designing and optimising global R&D organisational structures to maximise efficiency, collaboration, and innovation.
• Proven ability to attract, develop, and retain top-tier scientific and R&D leadership talent in a highly competitive market.
• Expertise in fostering a high-performance, psychologically safe culture that encourages scientific rigour, ethical conduct, and calculated risk-taking.
• Category: Financial Acumen & P&L Management
• Skills: Deep understanding of financial statements, budget planning, and capital allocation principles, particularly within a multi-£10M R&D context.
• Ability to construct and defend compelling business cases for significant R&D investments to the Board and investors.
• Experience in managing P&L responsibility for a large business unit or department, demonstrating fiscal discipline and value creation.

Functional Skills (Role-Specific Technical)

Your functional skills here are about strategic oversight and governance, not just hands-on work. You're setting the standards, challenging assumptions, and ensuring the right capabilities are in place across all our global labs.

Technical Competencies

• Skill: GLP/GCP/GMP Strategic Oversight
• Desc: A deep, practical understanding of Good Laboratory, Clinical, and Manufacturing Practices, not just at a compliance level, but how they strategically impact our entire development pipeline. You'll be defending our QMS strategy during regulatory audits and signing off on major system validations.
• Level: Expert
• Skill: Assay Development & Lifecycle Management (Platform Strategy)
• Desc: You'll define the strategic approach to assay development across the organisation, from initial proof-of-concept to method transfer and retirement. This includes setting global standards for validation and ensuring our analytical platforms are robust and future-proof.
• Level: Expert
• Skill: Design of Experiments (DoE) Strategic Application
• Desc: While you won't be running the experiments, you'll understand how DoE principles drive efficient scientific discovery and development. You'll challenge teams to use these methods to optimise processes and reduce experimental cycles across the portfolio.
• Level: Advanced
• Skill: Quality by Design (QbD) Enterprise Implementation
• Desc: You'll champion a QbD culture across all R&D activities, ensuring quality is proactively designed into every process and product. This means defining Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs) at an enterprise level.
• Level: Expert
• Skill: Technology Transfer & Global Standardisation
• Desc: You'll oversee the complex process of moving analytical methods or manufacturing processes between R&D, QC, and manufacturing sites globally. This includes ensuring all documentation, training, and validation are harmonised and robust across our international network.
• Level: Expert
• Skill: Regulatory Strategy & Agency Relations
• Desc: You'll define our global regulatory strategy, understanding the data requirements for key filings (IND, BLA, NDA, MAA) and building strong relationships with agencies like the FDA, EMA, and MHRA. You'll be the one defending our data package in high-stakes meetings.
• Level: Expert

Digital Tools

• Tool: Benchling / LabArchives (ELN)
• Level: Strategist
• Usage: Leads ELN platform selection, migration, and integration across global sites. Sets enterprise-level data integrity policies and ensures compliance with regulatory requirements. You're not using it day-to-day, but you're dictating how everyone else uses it.
• Tool: LabWare LIMS / STARLIMS
• Level: Strategist
• Usage: Approves LIMS capital expenditure for global rollouts. Oversees enterprise-wide system validation (CSV) and ensures LIMS strategy supports overall R&D and quality objectives. You're making the big decisions about the system's future.
• Tool: JMP / GraphPad Prism
• Level: Strategist
• Usage: Interprets high-level statistical outputs to make multi-million-pound go/no-go project decisions. Ensures the statistical capabilities across R&D are fit for purpose and support robust data analysis for regulatory submissions.
• Tool: Veeva QualityDocs / MasterControl (QMS)
• Level: Strategist
• Usage: Defends the global QMS strategy during critical regulatory audits (FDA/EMA). Signs off on major system changes and ensures the QMS supports a culture of quality and compliance across all R&D operations.
• Tool: Jira / MS Project
• Level: Strategist
• Usage: Manages the entire R&D portfolio at a strategic level, balancing resources across 10+ major projects. Reports overall progress and risks to steering committees and the Board, using these tools as a high-level oversight mechanism.
• Tool: SAP S/4HANA / Oracle NetSuite (ERP)
• Level: Strategist
• Usage: Develops and defends the multi-site, multi-million-pound annual R&D budget. Uses ERP data for strategic financial planning, cost control, and resource allocation across the global R&D organisation.
• Tool: Tableau / Power BI
• Level: Strategist
• Usage: Defines the key metrics and dashboards for the global R&D performance presented to the C-suite and Board. Uses these tools to monitor strategic KPIs and make high-level decisions about R&D efficiency and pipeline health.

Industry Knowledge

• Area: Global Pharmaceutical/Biotech Landscape
• Desc: Deep understanding of market dynamics, competitor pipelines, emerging therapeutic areas, and geopolitical factors impacting global R&D investment and strategy.
• Area: Drug Discovery & Development Lifecycle
• Desc: Comprehensive knowledge of the entire drug development process, from target identification and lead optimisation through to clinical trials, regulatory approval, and post-market surveillance. You've seen it all.
• Area: Intellectual Property (IP) Strategy
• Desc: Expertise in building and defending a robust IP portfolio, including patent strategy, freedom-to-operate analysis, and managing trade secrets to protect our scientific innovations.
• Area: Clinical Development & Medical Affairs Interface
• Desc: Strong understanding of how R&D data informs clinical trial design, medical affairs strategy, and ultimately, product commercialisation. You're working hand-in-glove with these teams.

Regulatory Compliance Regulations

• Reg: FDA 21 CFR Parts 11, 58, 210, 211
• Usage: Ensuring enterprise-wide compliance for electronic records, GLP, and GMP. Defending our systems and processes during FDA inspections and audits.
• Reg: EMA Guidelines (e.g., GMP Annex 1, Clinical Trials Directive)
• Usage: Driving harmonised compliance across European R&D operations, ensuring our data and processes meet stringent EU regulatory expectations for clinical trials and manufacturing.
• Reg: ICH Guidelines (e.g., Q2, Q7, Q9, Q10)
• Usage: Implementing and overseeing international harmonisation standards for analytical method validation, GMP, Quality Risk Management, and Pharmaceutical Quality Systems across all global R&D sites.
• Reg: Data Privacy Regulations (e.g., GDPR, CCPA)
• Usage: Ensuring all R&D activities involving patient data or personal information comply with global data privacy laws, working closely with Legal and Compliance teams.

Essential Prerequisites

• A minimum of 20 years of progressive experience in pharmaceutical or biotechnology R&D, with at least 10 years in senior leadership or executive roles (e.g., VP, R&D; Head of Global Labs).
• Demonstrable experience managing a multi-£10M R&D budget and P&L responsibility for a significant business unit or department.
• Proven track record of successfully bringing multiple innovative products through the R&D pipeline to regulatory submission or approval.
• Extensive experience leading and developing large, geographically dispersed scientific and R&D teams (100+ individuals, including other leaders).
• Significant experience interacting with and presenting to Boards of Directors, investors, and major regulatory agencies globally.
• Deep expertise in at least one major therapeutic area (e.g., Oncology, Neuroscience, Immunology) with a broad understanding across others.

Career Pathway Context

This role isn't an entry point; it's the culmination of a distinguished career in R&D leadership. You'll have already navigated complex scientific, regulatory, and commercial challenges, building a reputation for scientific acumen and strategic vision. Frankly, you've earned your stripes.

Qualifications & Credentials

Emerging Foundation Skills

• Skill: AI-Driven Drug Discovery & Development Strategy
• Why: AI and machine learning are rapidly transforming every stage of R&D, from target identification to clinical trial design. Leaders who can strategically integrate these tools will massively accelerate pipelines and reduce costs. This isn't just about efficiency; it's about entirely new ways of doing science.
• Concepts: [{'concept_name': 'Generative AI for novel compound design', 'description': 'Understanding how AI can create new molecular structures or protein sequences, speeding up early-stage discovery.'}, {'concept_name': 'Predictive analytics for clinical trial success', 'description': 'Using AI to forecast trial outcomes, identify optimal patient populations, and reduce failure rates.'}, {'concept_name': 'Ethical AI in R&D', 'description': 'Navigating the ethical implications of AI use, particularly regarding data bias and decision-making transparency.'}, {'concept_name': 'AI-powered automation of lab processes', 'description': 'Strategic oversight of robotic labs and automated data analysis pipelines.'}]
• Prepare: This quarter: Engage with leading AI research institutions and start-ups in drug discovery to understand their capabilities.
• Next 6 months: Commission an internal task force to identify 3-5 high-impact AI opportunities across our R&D pipeline.
• Month 7-12: Allocate significant budget to pilot 1-2 transformative AI projects, ensuring clear KPIs and success metrics.
• Annually: Present a comprehensive AI strategy and progress report to the Board, outlining long-term vision and investment.
• QuickWin: Start by sponsoring a series of internal 'AI in R&D' workshops for your leadership team, bringing in external experts to spark ideas and challenge current thinking. No need for huge investment yet, just education.
• Skill: Personalised Medicine & Diagnostics Integration
• Why: The shift towards personalised medicine requires tighter integration between drug development and companion diagnostics. You'll need to strategically blend these two worlds, which means navigating new regulatory pathways and commercial models. It's a fundamental change in how we approach treatment.
• Concepts: [{'concept_name': 'Co-development of drugs and diagnostics', 'description': 'Understanding the parallel pathways for developing a therapeutic and its associated diagnostic test.'}, {'concept_name': 'Regulatory frameworks for personalised medicine', 'description': 'Navigating the specific requirements from agencies like FDA and EMA for combined products.'}, {'concept_name': 'Real-world evidence (RWE) in drug development', 'description': 'Strategically using RWE to support regulatory submissions and market access for personalised therapies.'}, {'concept_name': 'Ethical considerations of genetic data', 'description': 'Ensuring robust ethical governance around patient genomic and health data.'}]
• Prepare: This quarter: Review our current pipeline for personalised medicine opportunities and identify gaps in diagnostic capabilities.
• Next 6 months: Establish a cross-functional task force (R&D, Clinical, Commercial, Regulatory) to develop a comprehensive personalised medicine strategy.
• Month 7-12: Forge strategic partnerships with leading diagnostic companies to enhance our capabilities and accelerate co-development.
• Annually: Report on the progress and strategic impact of our personalised medicine initiatives to the Board.
• QuickWin: Initiate a series of 'lunch and learn' sessions with external experts on the latest trends and challenges in personalised medicine. Get your leadership team thinking about this now.

Advancing Technical Skills

• Skill: Advanced Data Lake & FAIR Principles Governance
• Why: As R&D generates exponentially more data, simply storing it isn't enough. You'll need to ensure our data is Findable, Accessible, Interoperable, and Reusable (FAIR) across all global labs, which is crucial for AI integration and collaborative science. It's about making our data truly intelligent.
• Concepts: [{'concept_name': 'Enterprise data architecture for R&D', 'description': 'Designing scalable data infrastructure that integrates ELN, LIMS, and other data sources.'}, {'concept_name': 'Data standardisation and ontology development', 'description': 'Implementing common data models and controlled vocabularies across global R&D.'}, {'concept_name': 'Data security and access control', 'description': 'Ensuring robust governance for sensitive scientific and patient data.'}, {'concept_name': 'Cloud-native data platforms', 'description': 'Strategically leveraging cloud technologies for scalable data storage and processing.'}]
• Prepare: This quarter: Commission an audit of our current R&D data landscape against FAIR principles.
• Next 6 months: Develop a multi-year roadmap for building a unified R&D data lake, focusing on interoperability.
• Month 7-12: Secure budget and resources for a dedicated R&D Data Strategy team.
• Annually: Review progress on data harmonisation and its impact on R&D productivity and AI readiness.
• QuickWin: Mandate that all new R&D projects include a data management plan that explicitly addresses FAIR principles from day one. Start small, but start now.

Education Requirements

• Level: Minimum
• Req: PhD in a relevant life science discipline (e.g., Biochemistry, Molecular Biology, Pharmacology, Immunology, Medicinal Chemistry) from a globally recognised institution.
• Alts: Exceptional candidates with an MD and extensive research experience, or a Master's degree with 25+ years of demonstrable, transformative R&D leadership experience at a global level, may be considered.
• Level: Preferred
• Req: An MBA or equivalent business qualification, demonstrating a strong understanding of commercial strategy, finance, and organisational leadership.
• Alts: Significant executive education in business or leadership from a top-tier institution.

Experience Requirements

You'll need a minimum of 20 years of progressive leadership experience within pharmaceutical or biotechnology R&D, with at least 10 years spent in executive-level roles (e.g., VP, R&D; Head of Global Research; Chief Scientific Officer) managing large, multi-site, international teams. This must include direct P&L responsibility for a significant R&D budget (typically £10M+), a proven track record of successfully bringing multiple assets from discovery through to regulatory submission/approval, and extensive experience presenting to Boards of Directors, investors, and regulatory agencies.

Preferred Certifications

• Cert: Executive Leadership Programme
• Prod: Top-tier business schools (e.g., London Business School, INSEAD, Harvard Business School)
• Usage: Demonstrates a commitment to developing strategic leadership capabilities beyond pure scientific expertise, crucial for C-suite roles.
• Cert: Board Director Certification
• Prod: Institute of Directors (IoD) or similar governance bodies
• Usage: Provides a deeper understanding of corporate governance, fiduciary duties, and effective board interaction, which is essential for reporting to and working with the Board.

Recommended Activities

• Active participation and leadership roles in major industry associations (e.g., ABPI, BIA, PhRMA, BIO) and scientific societies.
• Regular engagement with venture capital firms and biotech incubators to stay abreast of emerging technologies and investment trends.
• Mentoring rising scientific leaders within and outside the organisation, contributing to the broader scientific community.
• Continuous learning in areas like AI/ML in drug discovery, advanced genomics, and global regulatory intelligence.

Career Progression Pathways

Entry Paths to This Role

• Path: VP, Global Research & Development at a large pharmaceutical company
• Time: 3-5 years in role before CRDO
• Path: Chief Scientific Officer (CSO) at a mid-sized biotech firm
• Time: 2-4 years in role before CRDO at a larger firm
• Path: Director, [Therapeutic Area] R&D at a top-tier academic institution or research hospital
• Time: Not a direct path; requires significant industry experience post-academia

Career Progression From This Role

• Pathway: Chief Executive Officer (CEO)
• Time: 3-7 years as CRDO
• Pathway: Board Member / Non-Executive Director (NED)
• Time: Immediately or within 1-3 years of CRDO

Long Term Vision Potential Roles

• Title: Venture Partner / Scientific Advisor (Private Equity/Venture Capital)
• Time: 5-10 years post-CRDO
• Title: Founder / CEO of a new Biotech Start-up
• Time: 5-10 years post-CRDO
• Title: Global Health / Policy Advisor (WHO, Gates Foundation, Government)
• Time: 10+ years post-CRDO

How Zavmo Delivers This Role's Development

DISCOVER Phase: Skills Gap Analysis

Zavmo maps your current competencies against all requirements in this job description through conversational assessment. We evaluate your foundation skills (communication, strategic thinking), functional skills (CRM expertise, negotiation), and readiness for career progression.

Output: Personalised skills gap heat map showing strengths and priorities, estimated time to competency, neurodiversity accommodations.

DISCUSS Phase: Personalised Learning Pathway

Based on your DISCOVER results, Zavmo creates a personalised learning plan prioritised by impact: foundation skills first, then functional skills. We adapt to your learning style, pace, and neurodiversity needs (ADHD, dyslexia, autism).

Output: Week-by-week schedule, each module linked to specific job responsibilities, checkpoints and milestones.

DELIVER Phase: Conversational Learning

Learn through conversation, not boring modules. Zavmo uses 10 conversation types (Socratic dialogue, role-play, coaching, case studies) to build competence. Practice difficult QBR presentations, negotiate tough renewals, and handle churn conversations in a safe AI environment before facing real clients.

Example: "For 'Stakeholder Mapping', Zavmo will guide you through analysing a complex enterprise account, identifying key decision-makers, and building an engagement strategy."

DEMONSTRATE Phase: Competency Assessment

Zavmo automatically builds your evidence portfolio as you learn. Every conversation, practice scenario, and application example is captured and mapped to NOS performance criteria. When ready, your portfolio supports OFQUAL qualification claims and demonstrates competence to employers.

Output: Competency matrix, evidence portfolio (downloadable), qualification readiness, career progression score.